...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZCC relationship to ZEL!

RVXoldtimer - That is a pretty good rendition of my understanding. There will likely be some parts that won't be exact but the general idea is spot on.

tada

Share
New Message
Please login to post a reply